Table 5.
Prognostic factors | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P * | HR | 95% CI | P ** | |
Age (<60 versus≥60 years) | 2.97 | 1.88–7.21 | 0.042 | 1.58 | 0.64–3.79 | 0.210 |
PS (0 versus 1–2) | 3.98 | 1.13–9.91 | 0.019 | 2.65 | 2.44–6.63 | 0.058 |
Differentiation (Well or moderate versus poor or undifferentiated) | 1.72 | 0.70–4.23 | 0.198 | |||
Stage (III versus IV) | 18.61 | 1.10–17.28 | 0.000 | 5.96 | 2.40–17.30 | 0.000 |
Response (Responder versus Nonresponder † ) | 2.31 | 0.85–5.96 | 0.063 | |||
Bcl‐2 expression (high versus low) | 2.09 | 0.78–5.62 | 0.075 | |||
MMP‐7 expression (high versus low) | 11.31 | 7.24–29.33 | 0.000 | 5.49 | 1.01–8.30 | 0.001 |
Abbreviation: PS, performance status; HR, hazard ratio; 95% CI, 95% confidence interval.
Log‐rank test.
Cox proportional‐hazards regression model.
Stable disease, progressive disease, not evaluable.